Funding Boost for New Trial Aiming to Tackle the Threat of Infection for Patients

Funding Boost for New Trial Aiming to Tackle the Threat of Infection for Patients

Experts at Swansea University are helping to test two potentially groundbreaking innovations in healthcare-associated infections (HCAIs). HCAIs are a major global challenge, made worse by the growing threat of antimicrobial resistance. These infections not only compromise patient safety but also place immense financial strain on healthcare systems. Infection control technology firm Vitec Microgenix Ltd has developed VSC1000, an antimicrobial sur…

The South Centre | Policy Brief 137, 14 March 2025

Leveraging the Antimicrobial Resistance Declarations of 2024 to Reduce the Burden of Drug-Resistant Infections By Afreenish Amir & Viviana Munoz Tellez In 2024, two significant events highlighted the global concern about antimicrobial resistance (AMR). AMR is a pressing global health issue, imperiling public health, economic stability, and societal well-being.  The 79th United Nations General Assembly (UNGA) in its special session on AMR and the…

Combating antimicrobial resistance in the UK and worldwide

Dr Louisa Jenkin details UKRI’s key activities contributing to UK and global efforts to drive down antimicrobial resistance.

A team of researchers from the Weizmann Institute of Sciences, led by Professor Yifat Merbl, conducted a mediated study that discovered an unexpected mechanism of the immune system that could offer new solutions against the growing threat of antibiotic resistance. Published in the prestigious journal Nature, the research revealed that certain peptides generated by the body itself in the process of protein degradation have a powerful antibacteria…